Grail [GRAL] vs Thermo Fisher [TMO] Detailed Stock Comparison
Grail
NASDAQ
Loading...
Thermo Fisher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Grail wins in 7 metrics, Thermo Fisher wins in 10 metrics, with 0 ties. Thermo Fisher appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Grail | Thermo Fisher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.49 | 28.17 | Grail |
| Price-to-Book Ratio | 0.49 | 3.64 | Grail |
| Debt-to-Equity Ratio | 2.69 | 69.62 | Grail |
| PEG Ratio | 0.01 | 4.96 | Grail |
| EV/EBITDA | -1.45 | 19.69 | Grail |
| Profit Margin (TTM) | -62.12% | 15.24% | Thermo Fisher |
| Operating Margin (TTM) | -368.15% | 17.84% | Thermo Fisher |
| EBITDA Margin (TTM) | N/A | 17.84% | N/A |
| Return on Equity | -17.68% | 13.42% | Thermo Fisher |
| Return on Assets (TTM) | -11.81% | 4.97% | Thermo Fisher |
| Free Cash Flow (TTM) | $-582.36M | $7.27B | Thermo Fisher |
| Dividend Yield | N/A | 0.31% | N/A |
| 1-Year Return | 115.12% | -20.19% | Grail |
| Price-to-Sales Ratio (TTM) | 8.43 | 4.26 | Thermo Fisher |
| Enterprise Value | $592.03M | $213.03B | Thermo Fisher |
| EV/Revenue Ratio | 4.41 | 4.93 | Grail |
| Gross Profit Margin (TTM) | -50.01% | 40.61% | Thermo Fisher |
| Revenue per Share (TTM) | $4 | $114 | Thermo Fisher |
| Earnings per Share (Diluted) | $-11.71 | $17.31 | Thermo Fisher |
| Beta (Stock Volatility) | N/A | 0.75 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Grail vs Thermo Fisher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Grail | 3.05% | 3.01% | -3.49% | -11.51% | -18.61% | 84.99% |
| Thermo Fisher | -2.23% | -0.26% | 19.46% | 21.46% | -9.16% | -7.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Grail | 115.12% | 126.74% | 126.74% | 126.74% | 126.74% | 126.74% |
| Thermo Fisher | -20.19% | -14.18% | 13.97% | 282.36% | 1,020.33% | 1,622.18% |
Performance & Financial Health Analysis: Grail vs Thermo Fisher
| Metric | GRAL | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $1.13B | $184.10B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 933,540 | 2,020,610 |
| 90 Day Avg. Volume | 970,810 | 2,900,827 |
| Last Close | $33.15 | $483.76 |
| 52 Week Range | $12.33 - $63.99 | $385.46 - $627.88 |
| % from 52W High | -48.20% | -22.95% |
| All-Time High | $63.99 (Feb 17, 2025) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -48.20% | -28.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.03% |
| Quarterly Earnings Growth | 0.11% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | -0.62% | 0.15% |
| Operating Margin (TTM) | -3.68% | 0.18% |
| Return on Equity (TTM) | -0.18% | 0.13% |
| Debt to Equity (MRQ) | 2.69 | 69.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $64.21 | $133.77 |
| Cash per Share (MRQ) | $16.72 | $16.92 |
| Operating Cash Flow (TTM) | $-370,048,000 | $7.58B |
| Levered Free Cash Flow (TTM) | $-142,499,120 | $5.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.31% |
| Last 12-Month Dividend | N/A | $1.21 |
Valuation & Enterprise Metrics Analysis: Grail vs Thermo Fisher
| Metric | GRAL | TMO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.49 | 28.17 |
| Forward P/E | -2.78 | 20.76 |
| PEG Ratio | 0.01 | 4.96 |
| Price to Sales (TTM) | 8.43 | 4.26 |
| Price to Book (MRQ) | 0.49 | 3.64 |
| Market Capitalization | ||
| Market Capitalization | $1.13B | $184.10B |
| Enterprise Value | $592.03M | $213.03B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.41 | 4.93 |
| Enterprise to EBITDA | -1.45 | 19.69 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.75 |
| Book Value per Share (MRQ) | $64.21 | $133.77 |
Financial Statements Comparison: Grail vs Thermo Fisher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GRAL | TMO |
|---|---|---|
| Revenue/Sales | $31.84M | $10.36B |
| Cost of Goods Sold | $51.77M | $6.13B |
| Gross Profit | $-19.93M | $4.24B |
| Research & Development | $53.63M | $342.00M |
| Operating Income (EBIT) | $-153.61M | $1.82B |
| EBITDA | $-114.33M | $2.73B |
| Pre-Tax Income | $-146.41M | $1.62B |
| Income Tax | $-40.20M | $95.00M |
| Net Income (Profit) | $-106.21M | $1.51B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GRAL | TMO |
|---|---|---|
| Cash & Equivalents | $133.90M | $4.13B |
| Total Current Assets | $727.66M | $23.38B |
| Total Current Liabilities | $74.98M | $13.17B |
| Long-Term Debt | $51.34M | $31.37B |
| Total Shareholders Equity | $2.41B | $49.49B |
| Retained Earnings | $-9.91B | $54.45B |
| Property, Plant & Equipment | $126.94M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GRAL | TMO |
|---|---|---|
| Operating Cash Flow | $-88.63M | $2.15B |
| Capital Expenditures | $-62,000 | $-350.00M |
| Free Cash Flow | $-95.07M | $361.00M |
| Debt Repayment | N/A | $-838.00M |
| Common Stock Repurchase | N/A | $-2.00B |
Short Interest & Institutional Ownership Analysis
| Metric | GRAL | TMO |
|---|---|---|
| Shares Short | 4.81M | 3.71M |
| Short Ratio | 4.38 | 1.14 |
| Short % of Float | 0.15% | 0.01% |
| Average Daily Volume (10 Day) | 933,540 | 2,020,610 |
| Average Daily Volume (90 Day) | 970,810 | 2,900,827 |
| Shares Outstanding | 33.89M | 380.77M |
| Float Shares | 24.19M | 376.76M |
| % Held by Insiders | 0.14% | 0.00% |
| % Held by Institutions | 0.73% | 0.92% |
Dividend Analysis & Yield Comparison: Grail vs Thermo Fisher
| Metric | GRAL | TMO |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.21 |
| Last 12-Month Dividend Yield | N/A | 0.31% |
| 3-Year Avg Annual Dividend | N/A | $1.33 |
| 3-Year Avg Dividend Yield | N/A | 0.07% |
| 3-Year Total Dividends | N/A | $3.99 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |